Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lefvert

Showing results (111-120 of 211) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|May 1, 1991
Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour loadS Bergenbrant, A Osterborg, G Holm, et al.
Atherosclerosis|April 27, 1999
C4 null alleles and myocardial infarctionS Nityanand, A Hamsten, H Lithell, et al.
Journal of Neuroimmunology|March 14, 2000
Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravisD Huang, R Giscombe, Y Zhou, et al.
Clinical Nephrology|November 1, 1992
Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsyU Widstam-Attorps, U Berg, S O Bohman, et al.
Scandinavian Journal of Rheumatology|March 30, 2005
beta2-adrenergic receptor gene single-nucleotide polymorphisms are associated with rheumatoid arthritis in northern SwedenB Xu, L Arlehag, S-B Rantapää-Dahlquist, et al.
Blood|December 29, 2005
Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia AJan Astermark, Johannes Oldenburg, Anna Pavlova, et al.
Stroke|December 3, 1999
Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control studyE Ahmed, J Trifunovic, B Stegmayr, et al.
European Journal of Immunology|September 1, 1982
A monoclonal anti-idiotypic antibody against anti-receptor antibodies from myasthenic seraA K Lefvert, R W James, C Alliod, et al.
Circulation|November 22, 2000
Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarctionA Mustafa, S Nityanand, L Berglund, et al.
Scandinavian Journal of Immunology|October 24, 2007
Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activationM Kakoulidou, R Giscombe, X Zhao, et al.
Pageof 22

Showing results (111-120 of 211) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|May 1, 1991
Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour loadS Bergenbrant, A Osterborg, G Holm, et al.
Atherosclerosis|April 27, 1999
C4 null alleles and myocardial infarctionS Nityanand, A Hamsten, H Lithell, et al.
Journal of Neuroimmunology|March 14, 2000
Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravisD Huang, R Giscombe, Y Zhou, et al.
Clinical Nephrology|November 1, 1992
Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsyU Widstam-Attorps, U Berg, S O Bohman, et al.
Scandinavian Journal of Rheumatology|March 30, 2005
beta2-adrenergic receptor gene single-nucleotide polymorphisms are associated with rheumatoid arthritis in northern SwedenB Xu, L Arlehag, S-B Rantapää-Dahlquist, et al.
Blood|December 29, 2005
Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia AJan Astermark, Johannes Oldenburg, Anna Pavlova, et al.
Stroke|December 3, 1999
Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control studyE Ahmed, J Trifunovic, B Stegmayr, et al.
European Journal of Immunology|September 1, 1982
A monoclonal anti-idiotypic antibody against anti-receptor antibodies from myasthenic seraA K Lefvert, R W James, C Alliod, et al.
Circulation|November 22, 2000
Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarctionA Mustafa, S Nityanand, L Berglund, et al.
Scandinavian Journal of Immunology|October 24, 2007
Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activationM Kakoulidou, R Giscombe, X Zhao, et al.
Pageof 22